NCT06819670View on ClinicalTrials.gov

A Study to Prevent Infantile Spasms Relapse

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

February 28, 2028

Study Completion Date

June 30, 2028

Conditions
Infantile SpasmsInfantile Epileptic Spasms SyndromeWest Syndrome
Interventions
DRUG

Prednisolone

active drug

DRUG

Famotidine

active drug

DRUG

Placebo

non-active drug

Trial Locations (1)

90095

RECRUITING

UCLA, Los Angeles

All Listed Sponsors
collaborator

Pediatric Epilepsy Research Foundation

UNKNOWN

lead

University of California, Los Angeles

OTHER